The global sperm bank market size was valued at USD 5 Billion in 2022 and is projected to reach USD 6.85 Billion by 2031, expanding at a CAGR of 3.56% during the forecast period, 2023-2031. The growth of the market is attributed to the innovations in cryopreservation techniques and rising cases of sperm fertility issues among married couples.
Sperm bank refers to a fertility preservation that freezes and stores sperms for future use. The sperm banks involve various function of collection, freezing and storage of human sperms. Sperm banking is generally opted by men, who have the possibility of losing fertility due to medical treatment such as cancer and infertility treatment.
Additionally, the sperm bank plays a significant role for the women who are unable to conceive and have complicacies during pregnancy. The stored sperms are used for couples undergoing infertility treatment such as assisted reproductive technology or in-vitro fertilization.
In 2017, Tommy’s, an organization funding research in the area of still births, premature births, and miscarriage in the UK, published an article stating that around 650 babies were miscarried per day. Additionally, obesity is a key risk factor for low sperm count in men and infertility among women. Men and women having fertility issues opt for artificial insemination techniques.
According to the American Association of Pregnancy, male infertility represents the 30% of the infertility cases, which is nearly one-fifth of all infertility cases. Apart from genetic problems, male infertility is caused due to genetic problems, illicit drugs, exposure to toxic substances, frequent alcohol consumption and smoking.
Various government initiatives are projected to boost the adoption of fertility treatments. For instance, the Government of Singapore implemented a policy to provide around 75% co-funding for several various assisted reproductive technology (ART) procedures, such as in vitro fertilization (IVF), gamete intrafallopian transfer (GIFT) and intracytoplasmic sperm injection (ICSI).
Similarly, the Government of Ontario, in December 2015, introduced a 50 million fertility program, which funded one cycle of IVF and unlimited artificial insemination and intra-uterine insemination treatments.
Additionally, the National Health Service (NHS) also formulated policies to fund the treatment for infertility across the U.K. The IVF treatment for single women and lesbian couples were made accessible in Malta, in June 2018, after Marie Louise Coleiro Preca, the Maltese President signed the Embryo Protection (Amendment).
Sperm Bank Market Drivers, Restraints, Trends, and Opportunities
- Growing awareness, rapid emergence of fertility tourism, and increasing access to infertility treatment are the prime factors boosting the market growth.
- Increasing cases related to fertility risk and incidence of miscarriages during pregnancy are propelling the market expansion during the forecast period.
- Rising prevalence of male and female infertility across the globe is fueling the acceptance of infertility services such as donor insemination and IVF procedures, thereby driving the market growth.
- Supportive governments’ initiatives and their rising funding to spur the adoption of fertility treatments, thereby boosting the market growth.
- Growing acceptance of single-parent and increasing acceptance of same-sex families in many societies are creating various opportunities for the market growth.
- The emergence of COVID-19 pandemic has adversely affected the market growth. The pandemic has forced to decline the sperm donation among donors. This factors is hindering the market growth.
Scope of Sperm Bank Market Report
The report on the global sperm bank market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Sperm Bank Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Service Types (Sperm Storage, Semen Analysis, and Genetic Consultation), Donor Types (Known and Anonymous), and End-users (Donor Insemination and In Vitro Fertilization)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Fairfax Cryobank, Inc., Xytex Corporation, Andocryos, Cryo-Save AG, Indian Spermtech, New England Cryogenic Center, Seattle Sperm Bank, and London Sperm Bank
|
Sperm Bank Market Segment Insights
Services Types Segment Analysis
On the basis of service types, the global sperm bank market is segregated into sperm storage, semen analysis, and genetic consultation. The semen analysis segment is projected to represent a considerable market share during the forecast period owing to rising demand for ART procedures and increasing need for advanced semen analysis solution.
Extensive analysis of semen is essential before any ART procedure and basic screening is mandatory while storing stores. Additionally, the growing preference for fertility tourism in countries such as India and Spain are further boosting the demand for semen analysis services. Supportive legal framework and cost effectiveness are the prime factors propelling the fertility tourism in these countries. Spain is a preferred destination for fertility treatments.
On the other hand, the sperm storage segment is anticipated to expand at a lucrative CAGR during the forecast period due to constant innovations in cryopreservation techniques, increasing prevalence of infertility, and demand for IVF procedures. Sperm storage is helpful to store fertility in case of medical treatments, surgery, high risk occupations such as military, and exposure to toxic environment.
Donor Types Segment Analysis
In terms of donor types, the market is bifurcated into known and anonymous. The known segment is anticipated to constitute a large market share during the forecast period. The growth of the segment is attributed to the changing legal policies in several countries which mandates the right to the offspring to know their biological parent. Austria, Switzerland, New Zealand, Sweden, the UK, and Australia are some of the countries having stringent laws against donor anonymity.
The New Hampshire based fertility law firm, New Hampshire Fertility Law PLLC, under the New Hampshire Law, has stated that the prospective parents have a reasonable alternative to use a known donor, after completing all the legal prerequisites.
The medical and behavioural background of the donor is ensured by the use of known donor. The Cryos International states, the total number of anonymous donors is much higher than known donors. However, the price of a known donor is much higher, which is also expected to boost the segment growth.
Meanwhile, the anonymous segment is expected to register a lucrative CAGR during the forecast period. An anonymous donor does not disclose his identity in any official records. However, in several countries it is made mandatorily to disclose donors to the recipient, by signing a confidentiality contract between the donor and recipient.
The process of using anonymous donor is less complex than that of a known donor. A large number of countries is inclining towards adoption of the policy to disclose the biological identity of the offspring. This is expected to adversely impact the market growth.
End-Users Segment Analysis
Based on end-users, the sperm bank market is bifurcated into donor insemination and in vitro fertilization (IVF). The IVF segment is expected to represent a significant market share during the forecast period owing to increasing awareness of consumers regarding the benefits of IVF procedures. Additionally, high cost of procedure is also a significant factor driving the market growth.
IVF is gaining significant tractions in countries such as Japan owing to the rising prevalence of infertility among male population and high maternal age among female population. Increasing incidence of Polycystic Ovary Syndrome (PCOS) and elimination of China’s one child policy are some of the other factors driving the segment growth.
Supportive reimbursement framework and funding enhances the access to IVF, which is projected to create various opportunities for the market growth. On the other hand, the donor insemination segment is anticipated to expand at a substantial CAGR during the forecast period.
Donor insemination is another technique for the fertility treatment. The donor insemination segment has a large consumer base owing to low cost and easy techniques. However, it has a low success rate than other fertility techniques, this in turn is projected to hamper the market growth during the forecast period.
Regional Analysis
In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is projected to register a high CAGR during the forecast period owing to growing prevalence of infertility among a large number of the population in the region.
For instance, in 2017, according to the US Department of Health and Human Services statistics, about 6.1 million women between the ages of 15 to 44 were facing issues in getting pregnant or staying pregnant.
The market in Europe, however, is anticipated to exhibit a healthy CAGR during the forecast period owing to various factors such as lower treatment cost compared to US and Canada along with the rising number of IVF centers in this region. Growing preference for fertility tourism is also propelling the regional demand.
Segments
Service Types
- Sperm Storage
- Semen Analysis
- Genetic Consultation
Donor Types
End-users
- Donor Insemination
- In Vitro Fertilization
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
Competitive Landscape
Some of the key players in the global sperm bank market include Fairfax Cryobank, Inc., Xytex Corporation, Andocryos, Cryo-Save AG, Indian Spermtech, New England Cryogenic Center, Seattle Sperm Bank, and London Sperm Bank. Key players are focusing on various initiatives to gain a competitive edge in the market. Additionally, key players are adopting strategies such as mergers and acquisitions. For instance,
- In July 2014, Xytex Corporation announced the launch of xyConnects, an online platform allowing the registration and communication of donors, parents, and offspring in social media settings.
- In August 2018, GI Partners completed the merger and acquisition of California Cryobank (CCB).
Request For Customization
Enquiry Before Buying
Speak With Analyst
